High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer

S. Bhatia, Rafat Abonour, P. Porcu, R. Seshadri, C. R. Nichols, Kenneth Cornetta, Lawrence Einhorn

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Purpose: To assess the role of high-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. Patients and Methods: From August 1992 to April 1995, 65 patients with testicular cancer were treated with high-dose carboplatin and etoposide followed by peripheral-blood stem-cell transplantation or autologous bone marrow transplantation rescue as initial salvage chemotherapy at Indiana University. An identical course was given after hematopoietic reconstitution. Postchemotherapy resection of residual disease was performed in selected patients with incomplete radiographic response associated with normalization of markers. The median follow-up was 39 months (range, 16 to 91 months). Results: Thirty-seven (57%) of the 65 patients are continuously disease-free. Three additional patients are disease-free with subsequent surgery. High-dose chemotherapy was associated with significant morbidity but no treatment-related mortality. Conclusion: High-dose chemotherapy as initial salvage chemotherapy achieved impressive long-term survival with acceptable toxicity in patients with relapsed testicular cancer. (C) 2000 by American Society of Clinical Oncology.

Original languageEnglish
Pages (from-to)3346-3351
Number of pages6
JournalJournal of Clinical Oncology
Volume18
Issue number19
StatePublished - Oct 1 2000

Fingerprint

Testicular Neoplasms
Drug Therapy
Peripheral Blood Stem Cell Transplantation
Autologous Transplantation
Carboplatin
Etoposide
Bone Marrow Transplantation
Morbidity
Survival
Mortality

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. / Bhatia, S.; Abonour, Rafat; Porcu, P.; Seshadri, R.; Nichols, C. R.; Cornetta, Kenneth; Einhorn, Lawrence.

In: Journal of Clinical Oncology, Vol. 18, No. 19, 01.10.2000, p. 3346-3351.

Research output: Contribution to journalArticle

@article{a8bc61264b3c4f9facd59cc593a7683b,
title = "High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer",
abstract = "Purpose: To assess the role of high-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. Patients and Methods: From August 1992 to April 1995, 65 patients with testicular cancer were treated with high-dose carboplatin and etoposide followed by peripheral-blood stem-cell transplantation or autologous bone marrow transplantation rescue as initial salvage chemotherapy at Indiana University. An identical course was given after hematopoietic reconstitution. Postchemotherapy resection of residual disease was performed in selected patients with incomplete radiographic response associated with normalization of markers. The median follow-up was 39 months (range, 16 to 91 months). Results: Thirty-seven (57{\%}) of the 65 patients are continuously disease-free. Three additional patients are disease-free with subsequent surgery. High-dose chemotherapy was associated with significant morbidity but no treatment-related mortality. Conclusion: High-dose chemotherapy as initial salvage chemotherapy achieved impressive long-term survival with acceptable toxicity in patients with relapsed testicular cancer. (C) 2000 by American Society of Clinical Oncology.",
author = "S. Bhatia and Rafat Abonour and P. Porcu and R. Seshadri and Nichols, {C. R.} and Kenneth Cornetta and Lawrence Einhorn",
year = "2000",
month = "10",
day = "1",
language = "English",
volume = "18",
pages = "3346--3351",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "19",

}

TY - JOUR

T1 - High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer

AU - Bhatia, S.

AU - Abonour, Rafat

AU - Porcu, P.

AU - Seshadri, R.

AU - Nichols, C. R.

AU - Cornetta, Kenneth

AU - Einhorn, Lawrence

PY - 2000/10/1

Y1 - 2000/10/1

N2 - Purpose: To assess the role of high-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. Patients and Methods: From August 1992 to April 1995, 65 patients with testicular cancer were treated with high-dose carboplatin and etoposide followed by peripheral-blood stem-cell transplantation or autologous bone marrow transplantation rescue as initial salvage chemotherapy at Indiana University. An identical course was given after hematopoietic reconstitution. Postchemotherapy resection of residual disease was performed in selected patients with incomplete radiographic response associated with normalization of markers. The median follow-up was 39 months (range, 16 to 91 months). Results: Thirty-seven (57%) of the 65 patients are continuously disease-free. Three additional patients are disease-free with subsequent surgery. High-dose chemotherapy was associated with significant morbidity but no treatment-related mortality. Conclusion: High-dose chemotherapy as initial salvage chemotherapy achieved impressive long-term survival with acceptable toxicity in patients with relapsed testicular cancer. (C) 2000 by American Society of Clinical Oncology.

AB - Purpose: To assess the role of high-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. Patients and Methods: From August 1992 to April 1995, 65 patients with testicular cancer were treated with high-dose carboplatin and etoposide followed by peripheral-blood stem-cell transplantation or autologous bone marrow transplantation rescue as initial salvage chemotherapy at Indiana University. An identical course was given after hematopoietic reconstitution. Postchemotherapy resection of residual disease was performed in selected patients with incomplete radiographic response associated with normalization of markers. The median follow-up was 39 months (range, 16 to 91 months). Results: Thirty-seven (57%) of the 65 patients are continuously disease-free. Three additional patients are disease-free with subsequent surgery. High-dose chemotherapy was associated with significant morbidity but no treatment-related mortality. Conclusion: High-dose chemotherapy as initial salvage chemotherapy achieved impressive long-term survival with acceptable toxicity in patients with relapsed testicular cancer. (C) 2000 by American Society of Clinical Oncology.

UR - http://www.scopus.com/inward/record.url?scp=0034306291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034306291&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 3346

EP - 3351

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -